News
- KWS BioTest has won a Biomedical iNet award!... more
- 51st ICAAC conference 2011... more
- KWS BioTest appoints first Non-Executive Director ... more
- KWS BioTest now on Twitter!... more
- Genesis 2011 conference... more
- 21st ECCMID/ 27th ICC conference 2011... more
- Quotient Bioresearch and KWS BioTest become partners... more
- BOS Non-clinical 2011 conference ... more
- EPIC 2011 conference ... more
- BioTrinity 2011 conference... more
- SMi Superbugs & Superdrugs conference... more
- New secure area of our website!... more
Shaping Tomorrow's Solutions
Providing Preclinical Contract Research for Efficacy Testing and Lead Compounds Development
Email: info@kwsbiotest.co.uk
Welcome to KWS Bio Test
KWS BioTest is a leading edge preclinical contract research organisation (CRO), which works closely with clients to develop lead compounds as novel treatments for human disease.
We provide efficacy models within the core areas of:
We work with clients to understand the unique attributes of each individual programme, to design appropriate research and development protocols and to develop a truly bespoke and individual service. In doing so, we draw from our extensive expertise and range of technical skills, and are continually developing and validating new services to meet the demands of the modern pharmaceutical industry.
KWS Bio Test – Providing preclinical contract research for efficacy testing and lead compounds development